Christopher G. V. Sharples

Author

University of Bath

Also Known As

C. G. V. SHARPLES, CHRISTOPHER G. V. SHARPLES, Christopher G. V. Sharples, Christopher G.V. Sharples

Publications

786

Citations

H-Index

Concepts

All Affiliations

University of Bath University of Bristol

About

Christopher G. V. Sharples is an author at University of Bath specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	524
2	Biochemistry	5	5	371
3	Natural Sciences	4	4	207
4	Social Sciences	2	2	296
5	Biomolecular Engineering	1	1	61

Christopher G. V. Sharples

Publications

781

Citations

H-Index

Page 1

	Year	Citations
UB-165: A Novel Nicotinic Agonist with Subtype Selectivity Implicates the α4β2* Subtype in the Modulation of Dopamine Release from Rat Striatal Synaptosomes Christopher G. V. Sharples, Sergio Kaiser, L. Soliakov, Journal of Neuroscience Synaptic TransmissionNeurotransmitterNeurotransmissionSynaptic SignalingSocial Sciences	2000	164
Neuronal nicotinic receptors Christopher G. V. Sharples, Susan Wonnacott Asian Journal of Neurosurgery	2001	141
Attentional effects of nicotinic agonists in rats Britta Hahn, Christopher G. V. Sharples, Susan Wonnacott, Neuropharmacology Tobacco ControlNeurophysiologyMedicineNicotinePsychopharmacology	2003	132
Agonist-Induced Up-Regulation of α4β2 Nicotinic Acetylcholine Receptors in M10 Cells: Pharmacological and Spatial Definition Paul Whiteaker, Christopher G. V. Sharples, Susan Wonnacott Molecular Pharmacology Molecular PharmacologySignal TransductionSynaptic SignalingSpatial DefinitionCell Signaling	1998	72
Molecular Recognition in Nicotinic Acetylcholine Receptors: The Importance of π−Cation Interactions Jeffrey D. Schmitt, Christopher G. V. Sharples, William S. Caldwell Journal of Medicinal Chemistry Austin MethodNeurotransmitterMolecular BiologyChemical BiologyNicotinic Ligands	1999	70
Synthesis of UB-165: A novel nicotinic ligand and anatoxin-a/epibatidine hybrid Emma Wright, Timothy Gallagher, Christopher G. V. Sharples, Bioorganic & Medicinal Chemistry Letters Diversity Oriented SynthesisBioorganic ChemistryBiochemistryNatural SciencesNovel Nicotinic Ligand	1997	61
Synthesis and Pharmacological Characterization of Novel Analogues of the Nicotinic Acetylcholine Receptor Agonist (±)-UB-165 Christopher G. V. Sharples, Gunter Karig, Graham L. Simpson, Journal of Medicinal Chemistry Pharmacological CharacterizationNovel AnaloguesChemical BiologyExperimental PharmacologyMolecular Pharmacology	2002	52
Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380 Adrian J. Mogg, Francis Avery Jones, Ian A. Pullar, Neuropharmacology Subunit CompositionSignal TransductionFunctional SelectivityMedicineSynaptic Transmission	2004	34
Synthesis of Two Fluoro Analogues of the Nicotinic Acetylcholine Receptor Agonist UB-165 Andrew Sutherland, Timothy Gallagher, Christopher G. V. Sharples, The Journal of Organic Chemistry	2003	31
Synthesis and nicotinic binding of novel phenyl derivatives of UB-165. Identifying factors associated with α7 selectivity Gunter Karig, Jonathan M. Large, Christopher G. V. Sharples, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryBiochemistryNatural Sciencesα7 SelectivityMolecular Biology	2003	24

Page 1